People · Operator
Named in public records as an officer, director or promoter · active 2017–2026 · Biotechnology, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| CoreMap, Inc. | — | Biotechnology | Series B | $39.8M | $47.3M | 2017 |
| CoreMap, Inc. | Executive Officer, Director | Other Technology | Series B | $35.5M | $132.5M | 2026 |
Sarah Kalil at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Sarah Kalil on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Adam Rothstein | 2 | 4 |
| Allen Kamer | 2 | 3 |
| Sarah O Kalil | 1 | 2 |
| Adam O Rothstein | 1 | 1 |
| Peter Spector | 1 | 1 |
| RONNY GINOR | 1 | 1 |
| Peter S Spector | 1 | 1 |
| William S Gruber | 1 | 1 |
| Gowri Raman | 1 | 1 |
| Allen O Kamer | 1 | 1 |
| Peter O Spector | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.